Evidence map›Paper›PMID 42292441›Full record

ArticleFrontiers in immunology2026

CD14

Jee Young Kim, Yong Jin Kim, Sang Jin Lee

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jee Young KimCardiovascular Research Institute, Daegu, Republic of Korea.
Yong Jin KimDepartment of Pathology, School of Medicine, Kyungpook National University, School of Medicine, Daegu, Republic of Korea.
Sang Jin LeeCardiovascular Research Institute, Daegu, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Scar-associated macrophages (SAMs), defined by triggering receptor expressed on myeloid cells 2 (TREM2) and/or glycoprotein-NMB (GPNMB) expression, have been implicated in lung fibrosis. This study investigated the characteristics and functional roles of SAMs in lung tissues from patients with systemic sclerosis-interstitial lung disease (SSc-ILD) and healthy controls (HCs). Methods: SAM-related transcriptional profiles of lung tissues from patients with SSc-ILD and HCs were analyzed using single-cell RNA sequencing (scRNA-seq). Immunofluorescence staining of lung tissues was performed to detect CD68-positive SAMs expressing TREM2 or CCL2. Monocytes from patients with SSc-ILD and HCs were differentiated with granulocyte-macrophage colony-stimulating factor (GM-CSF) or M-CSF. The population of TREM2- and GPNMB-expressing cells was assessed by flow cytometry, and the levels of CCL2 and TGF-β1 in culture supernatants were measured in an ELISA. The fibrotic effects of macrophages on fibroblasts were examined in co-cultures. TREM2 inhibition was used to determine functional relevance. Results: scRNA-seq revealed the expansion of TREM2 macrophages highly expressing SAM-associated genes in the lower lung lobes of SSc-ILD patients. Immunofluorescence showed increased numbers of CD68 Discussion: Our study identified a GM-CSF-TREM2-TGF-β1 axis driving monocytes-derived profibrotic macrophage-fibroblast crosstalk in SSc-ILD. It also showed that, in the lungs of SSc-ILD patients, CD14

Indexed as

Lung Diseases, InterstitialMacrophagesMembrane GlycoproteinsPulmonary FibrosisReceptors, ImmunologicScleroderma, SystemicFemaleFibroblastsGPI-Linked ProteinsHumansLipopolysaccharide ReceptorsLungMaleMiddle AgedMonocytesReceptors, IgGCD14 protein, humanGPI-Linked ProteinsGPNMB protein, humanLipopolysaccharide ReceptorsMembrane GlycoproteinsReceptors, IgGReceptors, ImmunologicTREM2 protein, humanbiomarkerslung fibrosismonocyte-derived macrophagessingle-cell RNA-sequencingsystemic sclerosis–associated interstitial lung disease

Identifiers

PMID42292441
PMCPMC13260380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.